Analysis
| Earnings estimate |
Current quarter (Dec 2025) |
Next quarter (Mar 2026) |
Current year (Jun 2026) |
Next year (Jun 2027) |
|---|---|---|---|---|
| Number of analysts | 33 | 33 | 41 | 42 |
| Average estimate | 3.86 | 3.91 | 15.72 | 18.63 |
| Low estimate | 3.41 | 3.48 | 14.36 | 16.37 |
| High estimate | 4.12 | 4.18 | 17.40 | 20.40 |
| Last year EPS | 3.23 | 3.46 | 13.64 | 15.72 |
| Revenue estimate |
Current quarter (Dec 2025) |
Next quarter (Mar 2026) |
Current year (Jun 2026) |
Next year (Jun 2027) |
|---|---|---|---|---|
| Number of Analysts | 41 | 40 | 51 | 52 |
| Avg. estimate | 80.28B | 81.25B | 326.83B | 375.59B |
| Low estimate | 78.58B | 78.70B | 320.45B | 354.04B |
| High estimate | 81.66B | 83.14B | 333.77B | 403.80B |
| Last year sales | 69.63B | 70.07B | 281.72B | 326.83B |
| Sales growth | 0.15 | 0.16 | 0.16 | 0.15 |
| EPS trend |
Current quarter (Dec 2025) |
Next quarter (Mar 2026) |
Current year (Jun 2026) |
Next year (Jun 2027) |
|---|---|---|---|---|
| Current estimate | 3.86 | 3.91 | 15.72 | 18.63 |
| 7 days ago | 3.86 | 3.92 | 15.73 | 18.62 |
| 30 days ago | 3.81 | 3.86 | 15.53 | 18.19 |
| 60 days ago | 3.81 | 3.86 | 15.53 | 18.19 |
| 90 days ago | 3.81 | 3.87 | 15.54 | 18.19 |
| EPS revisions |
Current quarter (Dec 2025) |
Next quarter (Mar 2026) |
Current year (Jun 2026) |
Next year (Jun 2027) |
|---|---|---|---|---|
| Up last 7 days | 0 | 1 | 3 | 2 |
| Up last 30 days | 20 | 18 | 24 | 29 |
| Down last 7 days | 0 | 0 | 0 | 0 |
| Down last 30 days | 6 | 7 | 9 | 4 |
| Growth estimates | |
|---|---|
| Current qtr (Nov 2025) | 0.209% |
| Next qtr. (Feb 2026) | 0.143% |
| Current year (2025) | 0.180% |
| Next 5 years (per annum) | 0.159% |
| Past 5 years (per annum) | 0.154% |
Recommendation
Buy